CVE-2016-8363

Description

An issue was discovered in Moxa OnCell OnCellG3470A-LTE, AWK-1131A/3131A/4131A Series, AWK-3191 Series, AWK-5232/6232 Series, AWK-1121/1127 Series, WAC-1001 V2 Series, WAC-2004 Series, AWK-3121-M12-RTG Series, AWK-3131-M12-RCC Series, AWK-5232-M12-RCC Series, TAP-6226 Series, AWK-3121/4121 Series, AWK-3131/4131 Series, and AWK-5222/6222 Series. User is able to execute arbitrary OS commands on the server.

Category

10.0
CVSS
Severity: Critical
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.29%
Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov
Affected: n/a Moxa OnCell
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-16-308-01 third party advisory us government resource
http://www.securityfocus.com/bid/94092 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2016-8363?
CVE-2016-8363 has been scored as a critical severity vulnerability.
How to fix CVE-2016-8363?
To fix CVE-2016-8363, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2016-8363 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2016-8363 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2016-8363?
CVE-2016-8363 affects n/a Moxa OnCell.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.